Global Ophthalmic Dye Market
Global Ophthalmic Dye Market

Ophthalmic Dye Comprehensive Study by Application (Ophthalmic Diagnosis, Ophthalmic Surgery), Drug (Fluorescein Dye, Rose Bengal Stain, Trypan Blue, Others), Distribution Channel (Hospital Pharmacies, Medical stores) Players and Region - Global Market Outlook to 2026

Ophthalmic Dye Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Apr 2021 Edition 216 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Ophthalmic Dye Market Overview:
The ophthalmic dyes are used to treat both anterior and posterior segment disorders as diagnostics and therapeutics. In the ophthalmic dye industry, there are a variety of dyes available, but the most widely used dyes are fluorescein and rose Bengal. Because of the growing geriatric population and age-related eye disorders, the global ophthalmic dyes market is growing. The rising prevalence of dry eye and ocular surface inflammation, especially among the elderly, is a major driver in the ophthalmic dye market. The rising prevalence of age-related macular degeneration is also expected to propel the ophthalmic dye market forward. Some of the players profiled in the study are Akorn, Inc. (United States), Novartis International AG (Switzerland), Altaire Pharmaceuticals, Inc. (United States), Johnson & Johnson (United States), Bausch Health (Canada), HUB Pharmaceuticals, LLC (United States), Abbott Laboratories (United States), Topcon Corporation (Japan), Carl-Zeiss-Stiftung (Germany) and Nomax, Inc. (United States).

On the basis of geography, the market of Ophthalmic Dye has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug, the sub-segment i.e. Fluorescein Dye will boost the Ophthalmic Dye market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Ophthalmic Dye market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers
  • Increasing Prevalence of Dry Eye
  • Rising Prevalence of Age-related Macular Degeneration

Influencing Trend
  • High Demand for Fluorescein Dye due to Convenient to Use as it Comes in the Form of Drops and Strips

Restraints
  • High Costs of Ophthalmic Diagnosis and Surgery

Opportunities
  • Rising Eye Infection Cases due to Air Pollution, Central Heating, Chemical Burns
  • Increasing Number of Patients Involvement in the Ophthalmic Diagnosis as Compared to Surgery

Challenges
  • Side Effects of Ocular Diagnostics such as Occasional Vomiting and Transient Nausea




Target Audience:
Ophthalmic Dye Manufacturers, Research Professionals, Emerging Companies, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Ophthalmic Dye market on the basis of product [] , application [Ophthalmic Diagnosis and Ophthalmic Surgery], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Ophthalmic Dye market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Ophthalmic Dye industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Ophthalmic Dye market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Report Objectives / Segmentation Covered
By Application
  • Ophthalmic Diagnosis
  • Ophthalmic Surgery
By Drug
  • Fluorescein Dye
  • Rose Bengal Stain
  • Trypan Blue
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Medical stores

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Dry Eye
      • 3.2.2. Rising Prevalence of Age-related Macular Degeneration
    • 3.3. Market Challenges
      • 3.3.1. Side Effects of Ocular Diagnostics such as Occasional Vomiting and Transient Nausea
    • 3.4. Market Trends
      • 3.4.1. High Demand for Fluorescein Dye due to Convenient to Use as it Comes in the Form of Drops and Strips
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ophthalmic Dye, by Application, Drug, Distribution Channel and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Ophthalmic Dye (Value)
      • 5.2.1. Global Ophthalmic Dye by: Application (Value)
        • 5.2.1.1. Ophthalmic Diagnosis
        • 5.2.1.2. Ophthalmic Surgery
      • 5.2.2. Global Ophthalmic Dye by: Drug (Value)
        • 5.2.2.1. Fluorescein Dye
        • 5.2.2.2. Rose Bengal Stain
        • 5.2.2.3. Trypan Blue
        • 5.2.2.4. Others
      • 5.2.3. Global Ophthalmic Dye by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Medical stores
      • 5.2.4. Global Ophthalmic Dye Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Ophthalmic Dye (Price)
  • 6. Ophthalmic Dye: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Akorn, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis International AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Altaire Pharmaceuticals, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Johnson & Johnson (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bausch Health (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. HUB Pharmaceuticals, LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Abbott Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Topcon Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Carl-Zeiss-Stiftung (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nomax, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Ophthalmic Dye Sale, by Application, Drug, Distribution Channel and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Ophthalmic Dye (Value)
      • 7.2.1. Global Ophthalmic Dye by: Application (Value)
        • 7.2.1.1. Ophthalmic Diagnosis
        • 7.2.1.2. Ophthalmic Surgery
      • 7.2.2. Global Ophthalmic Dye by: Drug (Value)
        • 7.2.2.1. Fluorescein Dye
        • 7.2.2.2. Rose Bengal Stain
        • 7.2.2.3. Trypan Blue
        • 7.2.2.4. Others
      • 7.2.3. Global Ophthalmic Dye by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Medical stores
      • 7.2.4. Global Ophthalmic Dye Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Ophthalmic Dye (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ophthalmic Dye: by Application(USD Million)
  • Table 2. Ophthalmic Dye Ophthalmic Diagnosis , by Region USD Million (2015-2020)
  • Table 3. Ophthalmic Dye Ophthalmic Surgery , by Region USD Million (2015-2020)
  • Table 4. Ophthalmic Dye: by Drug(USD Million)
  • Table 5. Ophthalmic Dye Fluorescein Dye , by Region USD Million (2015-2020)
  • Table 6. Ophthalmic Dye Rose Bengal Stain , by Region USD Million (2015-2020)
  • Table 7. Ophthalmic Dye Trypan Blue , by Region USD Million (2015-2020)
  • Table 8. Ophthalmic Dye Others , by Region USD Million (2015-2020)
  • Table 9. Ophthalmic Dye: by Distribution Channel(USD Million)
  • Table 10. Ophthalmic Dye Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 11. Ophthalmic Dye Medical stores , by Region USD Million (2015-2020)
  • Table 12. South America Ophthalmic Dye, by Country USD Million (2015-2020)
  • Table 13. South America Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 14. South America Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 15. South America Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 16. Brazil Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 17. Brazil Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 18. Brazil Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 19. Argentina Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 20. Argentina Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 21. Argentina Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 22. Rest of South America Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 23. Rest of South America Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 24. Rest of South America Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 25. Asia Pacific Ophthalmic Dye, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 27. Asia Pacific Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 28. Asia Pacific Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 29. China Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 30. China Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 31. China Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 32. Japan Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 33. Japan Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 34. Japan Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 35. India Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 36. India Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 37. India Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 38. South Korea Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 39. South Korea Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 40. South Korea Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 41. Taiwan Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 42. Taiwan Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 43. Taiwan Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 44. Australia Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 45. Australia Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 46. Australia Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 50. Europe Ophthalmic Dye, by Country USD Million (2015-2020)
  • Table 51. Europe Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 52. Europe Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 53. Europe Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 54. Germany Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 55. Germany Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 56. Germany Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 57. France Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 58. France Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 59. France Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 60. Italy Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 61. Italy Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 62. Italy Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 63. United Kingdom Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 64. United Kingdom Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 65. United Kingdom Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 66. Netherlands Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 67. Netherlands Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 68. Netherlands Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 69. Rest of Europe Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 70. Rest of Europe Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 71. Rest of Europe Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 72. MEA Ophthalmic Dye, by Country USD Million (2015-2020)
  • Table 73. MEA Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 74. MEA Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 75. MEA Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 76. Middle East Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 77. Middle East Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 78. Middle East Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 79. Africa Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 80. Africa Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 81. Africa Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 82. North America Ophthalmic Dye, by Country USD Million (2015-2020)
  • Table 83. North America Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 84. North America Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 85. North America Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 86. United States Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 87. United States Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 88. United States Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 89. Canada Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 90. Canada Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 91. Canada Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 92. Mexico Ophthalmic Dye, by Application USD Million (2015-2020)
  • Table 93. Mexico Ophthalmic Dye, by Drug USD Million (2015-2020)
  • Table 94. Mexico Ophthalmic Dye, by Distribution Channel USD Million (2015-2020)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Ophthalmic Dye: by Application(USD Million)
  • Table 106. Ophthalmic Dye Ophthalmic Diagnosis , by Region USD Million (2021-2026)
  • Table 107. Ophthalmic Dye Ophthalmic Surgery , by Region USD Million (2021-2026)
  • Table 108. Ophthalmic Dye: by Drug(USD Million)
  • Table 109. Ophthalmic Dye Fluorescein Dye , by Region USD Million (2021-2026)
  • Table 110. Ophthalmic Dye Rose Bengal Stain , by Region USD Million (2021-2026)
  • Table 111. Ophthalmic Dye Trypan Blue , by Region USD Million (2021-2026)
  • Table 112. Ophthalmic Dye Others , by Region USD Million (2021-2026)
  • Table 113. Ophthalmic Dye: by Distribution Channel(USD Million)
  • Table 114. Ophthalmic Dye Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 115. Ophthalmic Dye Medical stores , by Region USD Million (2021-2026)
  • Table 116. South America Ophthalmic Dye, by Country USD Million (2021-2026)
  • Table 117. South America Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 118. South America Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 119. South America Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 120. Brazil Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 121. Brazil Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 122. Brazil Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 123. Argentina Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 124. Argentina Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 125. Argentina Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 126. Rest of South America Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 127. Rest of South America Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 128. Rest of South America Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 129. Asia Pacific Ophthalmic Dye, by Country USD Million (2021-2026)
  • Table 130. Asia Pacific Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 131. Asia Pacific Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 132. Asia Pacific Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 133. China Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 134. China Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 135. China Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 136. Japan Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 137. Japan Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 138. Japan Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 139. India Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 140. India Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 141. India Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 142. South Korea Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 143. South Korea Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 144. South Korea Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 145. Taiwan Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 146. Taiwan Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 147. Taiwan Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 148. Australia Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 149. Australia Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 150. Australia Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 151. Rest of Asia-Pacific Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 154. Europe Ophthalmic Dye, by Country USD Million (2021-2026)
  • Table 155. Europe Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 156. Europe Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 157. Europe Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 158. Germany Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 159. Germany Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 160. Germany Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 161. France Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 162. France Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 163. France Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 164. Italy Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 165. Italy Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 166. Italy Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 167. United Kingdom Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 168. United Kingdom Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 169. United Kingdom Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 170. Netherlands Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 171. Netherlands Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 172. Netherlands Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 173. Rest of Europe Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 174. Rest of Europe Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 175. Rest of Europe Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 176. MEA Ophthalmic Dye, by Country USD Million (2021-2026)
  • Table 177. MEA Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 178. MEA Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 179. MEA Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 180. Middle East Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 181. Middle East Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 182. Middle East Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 183. Africa Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 184. Africa Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 185. Africa Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 186. North America Ophthalmic Dye, by Country USD Million (2021-2026)
  • Table 187. North America Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 188. North America Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 189. North America Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 190. United States Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 191. United States Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 192. United States Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 193. Canada Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 194. Canada Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 195. Canada Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 196. Mexico Ophthalmic Dye, by Application USD Million (2021-2026)
  • Table 197. Mexico Ophthalmic Dye, by Drug USD Million (2021-2026)
  • Table 198. Mexico Ophthalmic Dye, by Distribution Channel USD Million (2021-2026)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ophthalmic Dye: by Application USD Million (2015-2020)
  • Figure 5. Global Ophthalmic Dye: by Drug USD Million (2015-2020)
  • Figure 6. Global Ophthalmic Dye: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Ophthalmic Dye Share (%), by Country
  • Figure 8. Asia Pacific Ophthalmic Dye Share (%), by Country
  • Figure 9. Europe Ophthalmic Dye Share (%), by Country
  • Figure 10. MEA Ophthalmic Dye Share (%), by Country
  • Figure 11. North America Ophthalmic Dye Share (%), by Country
  • Figure 12. Global Ophthalmic Dye share by Players 2020 (%)
  • Figure 13. Global Ophthalmic Dye share by Players (Top 3) 2020(%)
  • Figure 14. Global Ophthalmic Dye share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Akorn, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Akorn, Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. Novartis International AG (Switzerland) Revenue: by Geography 2020
  • Figure 20. Altaire Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Altaire Pharmaceuticals, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 23. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 24. Bausch Health (Canada) Revenue, Net Income and Gross profit
  • Figure 25. Bausch Health (Canada) Revenue: by Geography 2020
  • Figure 26. HUB Pharmaceuticals, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 27. HUB Pharmaceuticals, LLC (United States) Revenue: by Geography 2020
  • Figure 28. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 29. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 30. Topcon Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Topcon Corporation (Japan) Revenue: by Geography 2020
  • Figure 32. Carl-Zeiss-Stiftung (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Carl-Zeiss-Stiftung (Germany) Revenue: by Geography 2020
  • Figure 34. Nomax, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Nomax, Inc. (United States) Revenue: by Geography 2020
  • Figure 36. Global Ophthalmic Dye: by Application USD Million (2021-2026)
  • Figure 37. Global Ophthalmic Dye: by Drug USD Million (2021-2026)
  • Figure 38. Global Ophthalmic Dye: by Distribution Channel USD Million (2021-2026)
  • Figure 39. South America Ophthalmic Dye Share (%), by Country
  • Figure 40. Asia Pacific Ophthalmic Dye Share (%), by Country
  • Figure 41. Europe Ophthalmic Dye Share (%), by Country
  • Figure 42. MEA Ophthalmic Dye Share (%), by Country
  • Figure 43. North America Ophthalmic Dye Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Akorn, Inc. (United States)
  • Novartis International AG (Switzerland)
  • Altaire Pharmaceuticals, Inc. (United States)
  • Johnson & Johnson (United States)
  • Bausch Health (Canada)
  • HUB Pharmaceuticals, LLC (United States)
  • Abbott Laboratories (United States)
  • Topcon Corporation (Japan)
  • Carl-Zeiss-Stiftung (Germany)
  • Nomax, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation